En este artculo, revisaremos los mecanismos de accin, y los efectos sobre control glucmico y reduccin de peso, en los programas de desarrollo clnico de los diferentes agonistas de GLP-1 actualmente en uso clnico y los que estn an en investigacin en los pacientes con DM2
Phase 3: Begin Medication + Monitoring Once your plan is in place, youll begin weekly injections
Gradually titrate the dosage of saxagliptin and metformin hydrochloride extended-release tablets, as needed, after assessing therapeutic response and tolerability, up to a maximum recommended dosage of saxagliptin and metformin hydrochloride extended-release tablets (5 mg for saxagliptin and 2,000 mg for metformin HCl extended-release orally once daily)
One strategy for extending the half-life of GLP-1 was therefore to develop formulations of DPP-4-resistant GLP-1 receptor activators
If there is a tiny drop of blood, press lightly with a cotton ball or gauze